257 related articles for article (PubMed ID: 35340165)
1. [Research Progress of Antibody-drug Conjugates in Advanced Non-small Cell Lung Cancer].
Wang N; Zhao L; Zhang D; Jia Y; Kong F
Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):214-218. PubMed ID: 35340165
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC).
Abuhelwa Z; Alloghbi A; Nagasaka M
Cancer Treat Rev; 2022 May; 106():102393. PubMed ID: 35472631
[TBL] [Abstract][Full Text] [Related]
3. [Current Progress and Future Developments of Antibody Drug Conjugates
in Lung Cancer].
Zhu Y; Wang Z
Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):468-476. PubMed ID: 35899443
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class.
Marks JA; Wilgucki M; Liu SV; Reuss JE
Curr Oncol Rep; 2022 Dec; 24(12):1829-1841. PubMed ID: 36197593
[TBL] [Abstract][Full Text] [Related]
5. Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies.
Passaro A; Jänne PA; Peters S
J Clin Oncol; 2023 Jul; 41(21):3747-3761. PubMed ID: 37224424
[TBL] [Abstract][Full Text] [Related]
6. Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments.
Reuss JE; Gosa L; Liu SV
Clin Lung Cancer; 2021 Nov; 22(6):483-499. PubMed ID: 34420859
[TBL] [Abstract][Full Text] [Related]
7. Pioneering the Way: The Revolutionary Potential of Antibody-Drug Conjugates in NSCLC.
Chen X; Zeng C
Curr Treat Options Oncol; 2024 Apr; 25(4):556-584. PubMed ID: 38520605
[TBL] [Abstract][Full Text] [Related]
8. Antibody Drug Conjugates in Lung Cancer.
Merle G; Friedlaender A; Desai A; Addeo A
Cancer J; 2022 Nov-Dec 01; 28(6):429-435. PubMed ID: 36383905
[TBL] [Abstract][Full Text] [Related]
9. Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985).
Xu Z; Guo D; Jiang Z; Tong R; Jiang P; Bai L; Chen L; Zhu Y; Guo C; Shi J; Yu D
Eur J Med Chem; 2019 Dec; 183():111682. PubMed ID: 31563805
[TBL] [Abstract][Full Text] [Related]
10. Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach.
Marks S; Naidoo J
Lung Cancer; 2022 Jan; 163():59-68. PubMed ID: 34923203
[TBL] [Abstract][Full Text] [Related]
11. Antibody-drug conjugates in advanced lung cancer: Is this a new frontier?
Reuss JE; Rosner S; Levy BP
Clin Adv Hematol Oncol; 2024 Jun; 22(5):217-226. PubMed ID: 38805313
[TBL] [Abstract][Full Text] [Related]
12. 'Targeting' Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer-An Updated Review.
Verma S; Breadner D; Raphael J
Curr Oncol; 2023 Apr; 30(4):4329-4350. PubMed ID: 37185443
[TBL] [Abstract][Full Text] [Related]
13. Antibody-drug conjugates in HER2-positive breast cancer.
Li L; Zhang D; Liu B; Lv D; Zhai J; Guan X; Yi Z; Ma F
Chin Med J (Engl); 2021 Dec; 135(3):261-267. PubMed ID: 34935688
[TBL] [Abstract][Full Text] [Related]
14. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
Chen H; Lin Z; Arnst KE; Miller DD; Li W
Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044
[TBL] [Abstract][Full Text] [Related]
15. Antibody drug conjugates in thoracic malignancies.
Pacheco JM; Camidge DR
Lung Cancer; 2018 Oct; 124():260-269. PubMed ID: 30268471
[TBL] [Abstract][Full Text] [Related]
16. A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer.
Huhe M; Lou J; Zhu Y; Zhao Y; Shi Y; Wang B; Sun X; Zhang X; Zhang Y; Chen ZN
Biochem Biophys Res Commun; 2019 Jun; 513(4):1083-1091. PubMed ID: 31010682
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal Antibodies, Small Molecule Inhibitors and Antibody-drug Conjugates as HER2 Inhibitors.
Li XF; Liu CF; Rao GW
Curr Med Chem; 2021; 28(17):3339-3360. PubMed ID: 32900344
[TBL] [Abstract][Full Text] [Related]
18. The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy.
Liu X; Deng J; Zhang R; Xing J; Wu Y; Chen W; Liang B; Xing D; Xu J; Zhang M
Front Immunol; 2023; 14():1335252. PubMed ID: 38162667
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.
Nagayama A; Ellisen LW; Chabner B; Bardia A
Target Oncol; 2017 Dec; 12(6):719-739. PubMed ID: 29116596
[TBL] [Abstract][Full Text] [Related]
20. Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer.
Desai A; Abdayem P; Adjei AA; Planchard D
Lung Cancer; 2022 Jan; 163():96-106. PubMed ID: 34942494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
